Tyra Biosciences, Inc. TYRA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s total liabilities & equity?
- Tyra Biosciences, Inc. (TYRA) reported total liabilities & equity of $412.04M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total liabilities & equity changed year-over-year?
- Tyra Biosciences, Inc.'s total liabilities & equity increased by 20.0% year-over-year, from $343.48M to $412.04M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total liabilities & equity has grown at a 77.6% compound annual growth rate (CAGR), from $16.01M to $282.61M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.